Literature DB >> 15702947

Comparing utility scores before and after hearing-aid provision : results according to the EQ-5D, HUI3 and SF-6D.

Garry R Barton1, John Bankart, Adrian C Davis, Quentin A Summerfield.   

Abstract

Utility scores were estimated for 609 hearing-impaired adults who completed EQ-5D, Health Utilities Index Mark III (HUI3) and SF-6D survey instruments both before and after being provided with a hearing aid. Pre-intervention, the mean utility scores for EQ-5D (0.80) and SF-6D (0.78) were significantly higher than the mean HUI3 utility score (0.58). Post-intervention, the mean improvement in the HUI3 (0.06 change) was significantly higher than the mean improvement according to the EQ-5D (0.01 change) or SF-6D (0.01 change). The estimated cost effectiveness of hearing-aid provision is therefore likely to be dependent on which instrument is used to measure utility.

Entities:  

Mesh:

Year:  2004        PMID: 15702947     DOI: 10.2165/00148365-200403020-00006

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  34 in total

1.  Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Authors:  Oriol Cunillera; Ricard Tresserras; Luis Rajmil; Gemma Vilagut; Pilar Brugulat; Mike Herdman; Anna Mompart; Antonia Medina; Yolanda Pardo; Jordi Alonso; John Brazier; Montse Ferrer
Journal:  Qual Life Res       Date:  2010-03-31       Impact factor: 4.147

Review 2.  Comparative studies on hearing aid selection and fitting procedures: a review of the literature.

Authors:  Mick Metselaar; Bert Maat; Hans Verschuure; Wouter A Dreschler; Louw Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-23       Impact factor: 2.503

Review 3.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3.

Authors:  Laura Smith-Olinde; Scott D Grosse; Frank Olinde; Patti F Martin; John M Tilford
Journal:  Qual Life Res       Date:  2008-05-17       Impact factor: 4.147

5.  The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common?

Authors:  Uwe Konerding; Jörn Moock; Thomas Kohlmann
Journal:  Qual Life Res       Date:  2009-09-01       Impact factor: 4.147

6.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

7.  Parental Health Spillover in Cost-Effectiveness Analysis: Evidence from Self-Harming Adolescents in England.

Authors:  Sandy Tubeuf; Eirini-Christina Saloniki; David Cottrell
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 8.  A review of the psychometric properties of generic utility measures in multiple sclerosis.

Authors:  Ayse Kuspinar; Nancy E Mayo
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

Review 9.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

10.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.